Evidence map›Paper›PMID 25712258›Full record

ReviewCurrent diabetes reports2015

Hospital readmission of patients with diabetes.

Daniel J Rubin

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03243383 nacompletednot on this mapstarted 2017, after this paper: background citation

A Pilot Trial to Prevent Hospital Readmission of Patients With Diabetes

TypeinterventionalSponsorTemple UniversityRan2017 to 2019Enrolled263ConditionsDiabetes MellitusArmsDiaTOHC Program
NCT07108426 nacompletednot on this mapstarted 2024, after this paper: background citation

Evaluation of the Impact of In-Person and Telemedicine-Based Medical Education on Diabetes Care and Outcomes in Hospitalized Patients

TypeinterventionalSponsorCatholic University of PelotasRan2024 to 2025Enrolled50ConditionsDiabete Type 2, Hyperglycemic Therapy, Medical Education, TelemedecineArmsEducational Intervention via Telemedicine
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2018
    Trial
  6. Postpartum Hospital Readmissions Among Women With Gestational Diabetes and Pregestational Diabetes in the United States, 2016 to 2022.Women's health issues : official publication of the Jacobs Institute of Women's Health · 2026
    Article
  7. Article
  8. Article
  9. Understanding Glycemia in the Post Discharge Period Through Blinded Continuous Glucose Monitoring.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026
    Observational
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Nomogram Predicting 90-Day Readmission in Patients with Diabetes: A Prospective Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Daniel J RubinSection of Endocrinology, Diabetes, and Metabolism, School of Medicine, Temple University, 3322 N. Broad ST., Ste 205, Philadelphia, PA, 19140, USA. djrubin@temple.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hospital readmission is a high-priority health care quality measure and target for cost reduction. Despite broad interest in readmission, relatively little research has focused on patients with diabetes. The burden of diabetes among hospitalized patients, however, is substantial, growing, and costly, and readmissions contribute a significant portion of this burden. Reducing readmission rates of diabetic patients has the potential to greatly reduce health care costs while simultaneously improving care. Risk factors for readmission in this population include lower socioeconomic status, racial/ethnic minority, comorbidity burden, public insurance, emergent or urgent admission, and a history of recent prior hospitalization. Hospitalized patients with diabetes may be at higher risk of readmission than those without diabetes. Potential ways to reduce readmission risk are inpatient education, specialty care, better discharge instructions, coordination of care, and post-discharge support. More studies are needed to test the effect of these interventions on the readmission rates of patients with diabetes.

Indexed as

Diabetes MellitusHumansPatient ReadmissionRisk FactorsRisk Reduction BehaviorUnited States

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.